Skip to content
healthcare.dev

Rasagiline

NDC 67877-259, Rasagiline, tablet, from Ascend Laboratories, LLC.

Product NDC
67877-259
Status
Listed
Labeler
Ascend Laboratories, LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA201889
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/67877-259 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • RASAGILINE MESYLATE.5 mg/1

Pharmacologic classes

Monoamine Oxidase Inhibitor [EPC]; Monoamine Oxidase Inhibitors [MoA]

Package NDCNDC-11Package
67877-259-306787702593030 TABLET in 1 BOTTLE (67877-259-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/5dfeec8f-f4f3-4e06-915e-3244467516a6
  • NADAC price for package 67877025930

    GET /v1/drugs/nadac/67877025930

Use it

Look up 67877-259 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/67877-259 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 67877-259. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.